Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Laboratory evidence suggests that vitamin D might influence prostate cancer prognosis.We examined the associations between prediagnostic plasma levels of 25(OH)vitamin D [25(OH)D] and 1,25(OH)(2) vitamin D [1,25(OH)(2)D] and mortality among 1822 participants of the Health Professionals Follow-up Stu...
Main Authors: | Fang Fang, Julie L Kasperzyk, Irene Shui, Whitney Hendrickson, Bruce W Hollis, Katja Fall, Jing Ma, J Michael Gaziano, Meir J Stampfer, Lorelei A Mucci, Edward Giovannucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3071841?pdf=render |
Similar Items
-
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
by: Haojie Li, et al.
Published: (2007-03-01) -
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
by: Feng, Xiaoshuang, et al.
Published: (2021) -
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
by: Feng, Xiaoshuang, et al.
Published: (2022) -
Prediagnostic adult body mass index change and esophageal adenocarcinoma survival
by: Elizabeth A. Loehrer, et al.
Published: (2020-05-01) -
Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density
by: Benedetta Bendinelli, et al.
Published: (2021-06-01)